Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study
7 auth. M. Ruggeri, A. Bellasi, F. Cipriani, D. Molony, C. Bell, D. Russo, ... B. Iorio